AF
IRMD icon

Allworth Financial’s iRadimed IRMD Stock Holding History

Allworth Financial’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.69K Buy
70
+5
+8% +$455 ﹤0.01% 3969
2026
Q1 		$6.26K Buy
65
+18
+38% +$1.8K ﹤0.01% 3818
2025
Q4 		$4.57K Buy
47
+11
+31% +$944 ﹤0.01% 3766
2025
Q3 		$2.56K Buy
36
+35
+3,500% +$2.33K ﹤0.01% 3890
2025
Q2 		$60 Buy
+1
New +$55 ﹤0.01% 4436
2022
Q1 		– Sell
-184
Closed -$9K – 2241
2021
Q4 		$9K Buy
+184
New +$7.42K ﹤0.01% 1404

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allworth Financial's IRMD Position: Q2 2026 in Review

Allworth Financial increased its iRadimed (IRMD) stake by 7.7% in Q2 2026, buying an estimated $455 and bringing the position to 70 shares worth $6.69K. The position accounts for ﹤0.01% of the portfolio, ranked #3969.

Allworth Financial first reported a position in IRMD in Q4 2021 and has held it in 6 quarters since. The position peaked at $9K in Q4 2021. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Allworth Financial held 70 shares of iRadimed worth $6.69K as of Q2 2026.
  • Allworth Financial bought 5 iRadimed shares in Q2 2026, an estimated $455.
  • iRadimed made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3969 holding.
  • Allworth Financial first reported a position in iRadimed in Q4 2021 and has held it in 6 quarters since.
  • Allworth Financial's iRadimed position peaked at $9K in Q4 2021.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.